Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Genentech, Inc.
With
Novartis
Age
Any age
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
\- Women who have been exposed to at least one dose of Xolair® (whether inadvertent or deliberate) within 8 weeks prior to conception or during pregnancy
You may not be if
Women not currently pregnant
Women exposed to Xolair® not during pregnancy but only while breastfeeding
Re-enrollment of women who are pregnant for second (or more) time is not allowed
Clareo Health | An Observational Study of the Use and Safety of Xolair® During Pregnancy
